Protein mutations can cause cellular proteins to stall or degrade before reaching their functional location, disrupting brain activity. This research investigates whether such delivery failures contribute to autism. By using drugs that stabilize damaged proteins, scientists may restore their function and enable personalized treatments based on underlying molecular causes.